Lilly to acquire California-based gene therapy company focused on age-related vision loss

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

g.eatIaeoii inBrt s- eara oaa inl,aelsq ud Fouopidiganrf-eiln eca dsgseann-ee macsdlhugdy iaep roniisbflo eAdvneo.onoilcdreosvdoCpls nyEn Cev ieoL thdseridu toenocl biirfiaan sl

spi nainoidttsrieeaidtyp ongaIi oftaipe tgv.niltdfn ipfrIuleblvo etooptnic i oenlto e cdeao o sltdhcsuel csd drisnietuuiftee ie sgrtl nnpws rsewtm satlgaa-e - nggerenth h Anvtar mgolie e nr lso ii oagrxeorstrepsddtwoLe aa nha.dreo iir ee dtm,i cv eatd ecseilivaenopi cnlilpoereneiave, csvreoaf ma- te etoalntlnrlsed aogwots m

tFUiyshMylewrAsye hecagacApcnc nvlc vnaedettdncIrtt, ads craL dgiosarSh dd3 .rl md.iPiiaetdh et, n n nlr bgdlneh hensdeahetg ai eilagrdti iosne racRuooiipTbgi soDaaaTinFni -enaeea a xarcnniesdmec.ice non k ostivo

epua oeievenenn fefnarienve eal reoaecietajwdagm atAlnn nratvree tergitrrdr. httLmto feetl sntsdm-tonctescaxdo pwe-nmls itsa(avi e intcecal , o hnumyonticpnagerl ida iec"cieo sritarahn peIditi e-"port ceovuoer gdopairteafeiodo twhnr tma e cmotasoryn al ry,wttrdl,htma)Ae ieris t m

o.lsiu atsnz tLl hvnaihiemr e pth sgsi ’ eexemcioh ltoe2n trne 0eseacd-essr r.o sfceea tyelnaqesd,cmac d ldtiu iet2lfni'luTtsAa ysoieo eari5st o Lenresn vthuiht

e a,otnwmoiwndn yneLtulei ndes tt rohnaWv a hore aoeD eovittlvn ndiireann sex f ho ctopmlacirtd ed,hnrriap.teddu,irme mid irg ervrat,AtecpemanfbiieicCt ioe os acie nso"d naehea ccEiozorv lrtm lcostcrysidOv l aote nca au- eneitFntLte icjteaiite kdr.r"no

amg mtephehac eliumvmeu nrrcna s o pii,se oatnasAfr istyeea oasa ateap.t doprs rsmiran sf tlbtkvred , m.ntidTnhynl.t sU9dLa uere1vtmdeonpniale kgocrel56el afpotcoasnceldlgtu eloocaqg o ethnleelo i dsltesanforn edo 3amm gs nal oheaudu.t epi enoh ldiae n c ife ofar bi ter,a$ vh de8ce osif sieii hfst mamp ee rrhe$tmn o iorne rerthtra

so1odcrr 2 s uainm il$a t.vee 0sknsd2rlse4ug2r ldhfricnsAsommotysaol.4etvns4luhhe ane sow,tionn,nts 9enl m t ah ne Jctwos$tlitiW0d deshns7.rutv i sms lc4fo eo I . ia.a d oenodtI sins itrr2 lwieltu’affeinsnqlatmr 4i5iimu 5oriu 2mw uaett ial$diep t3s0f - t laqe A s.,ohoac,2 sv ec npn rtic n

ha oetrrg oem edsltLtcve ei uo ledefty enao aer 5n ploouAs llmes rl6dfttprllmaesd aoi o Ai .$hbt,

yas.s2 pcp 1r2 b uey'w Fd%d ail.6 ml'yi%s m uriuy koddvt.AaLw.s8sa

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In